Your browser doesn't support javascript.
loading
Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central European Cooperative Oncology Group (CECOG).
Thallinger, Christiane; Berzinec, Peter; Bicakcic, Emina; Dan, Adelina; Fabian, Gabriella; Gales, Laurentia Nicoletta; Kuhar, Cvetka Grasic; Janzic, Urska; Kahan, Zsusanna; Mencinger, Marina; Penthedourakis, George; Sgouros, Joseph; Simetic, Luka; Sirbu, Daniela; Vosmik, Milan; Wrona, Anna; Zielinski, Christoph.
Afiliación
  • Thallinger C; Central European Cooperative Oncology Group, Ohmanngasse 26, 1190, Vienna, Austria. christiane.thallinger@cancer-center.cc.
  • Berzinec P; Department of Medicine I, Medical University Vienna-General Hospital, Waehringer Guertel 18-20, 1090, Vienna, Austria. christiane.thallinger@cancer-center.cc.
  • Bicakcic E; Department of Oncology at the Hospital of St Zoerardus Zobor, Nitra, Teaching Base of the Slovak Medical University Bratislava, Bratislava, Slovakia.
  • Dan A; Oncology Unit, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina.
  • Fabian G; Department of Medical Oncology at Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania.
  • Gales LN; Department of Oncotherapy, University of Szeged, Szeged, Hungary.
  • Kuhar CG; Department of Oncology at UMF "Carol Davila", Bucharest, Romania.
  • Janzic U; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Kahan Z; Department of Medical Oncology, University Clinic Golnik, Golnik, Slovenia.
  • Mencinger M; Department of Oncotherapy, University of Szeged, Szeged, Hungary.
  • Penthedourakis G; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Sgouros J; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Simetic L; 3rd Medical Oncology Department, "Agii Anargiri" General Hospital and Cancer Center, Athens, Greece.
  • Sirbu D; Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Vosmik M; Oncohelp Oncology Center, Timisoara, Romania.
  • Wrona A; Department of Oncology and Radiotherapy, University Hospital Hradec Králové, Hradec Králové, Czech Republic.
  • Zielinski C; Department of Oncology and Radiotherapy, Medical University Gdansk, Gdansk, Poland.
Wien Klin Wochenschr ; 134(19-20): 697-704, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35312859
PURPOSE: To establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). METHODS: We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. RESULTS: A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). CONCLUSION: When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV­2 (severe acute respiratory syndrome coronavirus type 2) pandemic.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Pulmonares Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Wien Klin Wochenschr Año: 2022 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Pulmonares Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Wien Klin Wochenschr Año: 2022 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Austria